Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


15 diciembre 2015

INTERNATIONAL JOURNAL OF CARDIOLOGY. Safety and efficacy of everolimus-eluting stent versus zotarolimus-eluting stent: A meta-analysis of randomized controlled clinical trials and observational studies

Hongqiu Gu12, Kun Hua13, Wei Li, Yang Wang2, Jingan Yang3

Background: The safety and efficacy of everolimus-eluting stent (EES) versus zotarolimus-eluting stent (ZES) are controversial both in randomized controlled clinical trials (RCTs) and observational studies. The aim of this study was to assess the safety and efficacy of EES versus ZES.

01 diciembre 2015

CANADIAN JOURNAL OF CARDIOLOGY. Transfemoral vs Non-transfemoral Access for Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

Jaya Chandrasekhar, MBBS, Benjamin Hibbert, MD, PhD, Marc Ruel, MD, Buu-Khanh Lam, MD, Marino Labinaz, MD, Christopher Glover, MD

Background: Transcatheter aortic valve implantation (TAVI) is the definitive therapy for high-risk patients with severe aortic stenosis. The aim of this study was to determine the effect of non-transfemoral access on clinical outcomes in TAVI.

01 diciembre 2015

CANADIAN JOURNAL OF CARDIOLOGY. Transcatheter Left Atrial Appendage Closure Using Intracardiac Echocardiographic Guidance From the Left Atrium

Jean-Bernard Masson, MD, FRCPC, Rémi Kouz, MD, MSc, Mounir Riahi, MD, Hien Kiem Nguyen Thanh, MD, Jeannot Potvin, MD, FRCPC, Charbel Naim, MD, Reda Salem, MD, FRCPC, Jean-Marc Raymond, MD, FRCPC

Background: Most commonly, left atrial appendage (LAA) occlusion procedures are performed using transesophageal echocardiography (TEE) guidance and general anaesthesia. Intracardiac echocardiography (ICE) offers potential advantages over TEE, however, ICE-guided LAA occlusion experience is limited and has been typically performed from a right-sided location where LAA visualization might be suboptimal. We sought to evaluate the efficacy and safety of percutaneous LAA occlusion using ICE guidance performed from the left atrium.

01 octubre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: The International MGuard Prime Observational Study (IMOS Prime)

Giovanni Amoroso MD, PhD1,*, Nicola S. Vos MD1, Jan A.S. Van der Heyden MD, PhD2, Renė J. van der Schaaf MD1, Mark S. Patterson MD1, Maarten A. Vink MD1, Jean-Paul Herrman MD1 andTon Slagboom MD1

Aims: We sought to evaluate the procedural and clinical performances of the MGuard Prime Embolic Protection Stent (EPS) in a “real-world” population with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).

01 octubre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: The nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial

Freek Nijhoff MD1, Pierfrancesco Agostoni MD, PhD1, Anouar Belkacemi MD, PhD2, Hendrik M. Nathoe MD, PhD1, Michiel Voskuil MD, PhD1, Mariam Samim MD1, Pieter A. Doevendans MD, PhD1 andPieter R. Stella MD, PhD1,*

Objective: To evaluate a paclitaxel drug-eluting balloon (DEB) only strategy in primary percutaneous coronary intervention (PPCI), aiming at a comparison with bare metal stent (BMS) alone, DEB followed by BMS, and paclitaxel eluting stent (PES), as assessed in the randomized Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction (DEB-AMI) trial.

01 octubre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Utility of rotational atherectomy and outcomes over an eight-year period

Lachlan T. Couper MBBS1, Philippa Loane BMedSci2, Nick Andrianopoulos MBBS, MBiostat2, Angela Brennan RN2, Shane Nanayakkara MBBS1, Nitesh Nerlekar MBBS1, Peter Scott MD3, Anthony S. Walton FRACP1, David J. Clark FRACP3, Stephen J. Duffy PhD1,2, Andrew E Ajani MD2,4, Chris Reid PhD2, James A. Shaw PhD1,* andon behalf of the Melbourne Interventional Group (MIG) Investigators

Objectives: To evaluate outcomes of patients undergoing rotational atherectomy (RA) in a multicenter percutaneous coronary intervention (PCI) registry.

01 octubre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transcatheter balloon dilation for recurrent right ventricular outflow tract obstruction following valve-sparing repair of tetralogy of Fallot

Laura Gellis MD1, Puja Banka MD2, Audrey Marshall MD1, Sitaram Emani MD3 andDiego Porras MD1,*

Background: Valve-sparing repair in patients with tetralogy of Fallot (TOF) carries the risk of residual or recurrent right ventricular outflow tract (RVOT) obstruction, which is often treated with transcatheter balloon dilation (BD). The outcomes and associated complications of BD of the RVOT in this scenario remain unknown.

01 octubre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome

Mohammad Khalid Mojadidi MD1, Rubine Gevorgyan MD2, Nabil Noureddin MD2 andJonathan M. Tobis MD, FACC2,†,*

Background: Platypnea-orthodeoxia syndrome is a rare condition characterized by hypoxemia in the upright position that is improved in the supine position. Although several etiologies of platypnea-orthodeoxia exist, it is frequently associated with right-to-left shunting of blood at the cardiac or pulmonary level, usually via a patent foramen ovale (PFO). The aim of this study was to evaluate the incidence of platypnea-orthodeoxia syndrome in a select patient population with right-to-left shunting and to describe the outcomes after PFO closure.

01 octubre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk

Gerhard Schymik MD1,*, Martin Heimeshoff MD2, Peter Bramlage MD, PhD3, Tanja Herbinger MD1, Alexander Würth MD4, Lothar Pilz PhD5, Jan S. Schymik MSc6, Rainer Wondraschek MD1, Tim Süselbeck MD7, Jan Gerhardus MD2, Armin Luik MD1, Bernd-Dieter Gonska MD4, Panagiotis Tzamalis MD1, Herbert Posival MD2, Claus Schmitt MD1 andHolger Schröfel MD2

Objectives: To assess outcomes for patients undergoing transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement but with less than high risk.

01 octubre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A 12–month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction

Janusz Kochman MD, PhD1,*, Mariusz Tomaniak MD1, Łukasz Kołtowski MD, PhD1, Jacek Jąkała MD, PhD2, Klaudia Proniewska MSC, PhD2, Jacek Legutko MD, PhD3, Tomasz Roleder MD, PhD2, Arkadiusz Pietrasik MD, PhD1, Adam Rdzanek MD, PhD1, Wacław Kochman MD, PhD4, Salvatore Brugaletta MD, PhD5 andGrzegorz L. Kaluza MD, PhD5

Objectives: The aim of the study was to evaluate the healing process at 12 months after ABSORB™ bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI).

01 noviembre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transcatheter melody valve placement in large diameter bioprostheses and conduits: What is the optimal “Landing zone”?

Will Finch MD1,*, Daniel S. Levi MD1,2, Morris Salem MD3, Abbie Hageman1 andJamil Aboulhosn MD1,2

Objectives: This study sought to elucidate the optimal bioprosthetic valve (BPV) size prior to Melody valve implantation. Background: BPVs provide an ideal “landing zone” for future Melody valve insertion. To guide surgical choice of BPV size, it is important to understand which BPV size can serve consistently as substrates for Melody valve placements.

15 octubre 2015

INTERNATIONAL JOURNAL OF CARDIOLOGY. Comparative meta-analysis of balloon-expandable and self-expandable valves for transcatheter aortic valve replacement

Shikhar Agarwal, Akhil Parashar, Dharam J. Kumbhani, Lars G. Svensson, Amar Krishnaswamy, E. Murat Tuzcu, Samir R. Kapadia

Background: Balloon-expandable valves (BEVs) and self-expandable valves (SEVs) are two major types of valves utilized for transcatheter aortic valve replacement (TAVR). We conducted a meta-analysis of available studies to compare the safety and efficacy of these two valve types.

01 noviembre 2015

INTERNATIONAL JOURNAL OF CARDIOLOGY. Effect of advanced chronic kidney disease in clinical and echocardiographic outcomes of patients treated with MitraClip system

Rodrigo Estévez-Loureiro, Magnus Settergren, Michele Pighi, Reidar Winter, Gianni D´Allara, Per Jacobsen, Lars Sondergaard, Gary Cheung, Matteo Ghione, Nikolaj Ihlemann, Neil E. Moat, Susanna Price, Tine Streit Rosenberg, Carlo Di Mario, Olaf Franzen

Background: Data regarding the influence of different levels of renal dysfunction on clinical and echocardiographic results of MitraClip therapy are scarce. We aimed to evaluate the impact of baseline advance renal failure in the outcomes of a cohort of patients treated with MitraClip.

01 noviembre 2015

INTERNATIONAL JOURNAL OF CARDIOLOGY. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry

Georgios Christopoulos, Dimitri Karmpaliotis, Khaldoon Alaswad, Robert W. Yeh, Farouc A. Jaffer, R. Michael Wyman, William L. Lombardi, Rohan V. Menon, J. Aaron Grantham, David E. Kandzari, Nicholas Lembo, Jeffrey W. Moses, Ajay J. Kirtane, Manish Parikh, Philip Green, Matthew Finn, Santiago Garcia, Anthony Doing, Mitul Patel, John Bahadorani, Muhammad Nauman J. Tarar, Georgios E. Christakopoulos, Craig A. Thompson, Subhash Banerjee, Emmanouil S. Brilakis

Background: A hybrid approach to chronic total occlusion (CTO) percutaneous coronary intervention (PCI) prioritizing and combining all available crossing techniques was developed to optimize procedural efficacy, efficiency, and safety, but there is limited published data on its outcomes.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.